Relmada Therapeutics, Inc. RLMD Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share)?
- Relmada Therapeutics, Inc. (RLMD) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.